CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-19 | Rubin Jami Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2021-05-19 | Murcko Mark Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2021-05-19 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2021-05-19 | INGRAM DOUGLAS S Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2021-05-19 | HILL LINDA A Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2021-04-26 | Adams Brian General Counsel | Option exercise | +6,500 | $4.12 | $27K | 32,370 |
| 2021-04-26 | Adams Brian General Counsel | Sale | −6,500 | $35.00 | $228K | 25,870 |
| 2021-04-26 | Adams Brian General Counsel | Option exercise · Stock Option (Right to Buy) | −6,500 | 160,286 | ||
| 2021-04-16 | Bergstrom Donald A See Remarks | Sale | −56,324 | $32.36 | $1.8M | 77,241 |
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Option exercise | +22,500 | $4.12 | $93K | 38,370 |
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Sale | −22,500 | $35.00 | $788K | 15,870 |
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −22,500 | 107,043 | ||
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Option exercise | +22,500 | $4.12 | $93K | 22,500 |
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Sale | −22,500 | $35.00 | $788K | 0 |
| 2021-03-30 | Catinazzo Thomas Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −22,500 | 107,043 | ||
| 2021-03-26 | Bergstrom Donald A See Remarks | Grant or award | +34,999 | 133,565 | ||
| 2021-03-26 | Bergstrom Donald A See Remarks | Grant or award · Stock Option (Right to Buy) | +69,998 | 69,998 | ||
| 2021-03-26 | Patel Sanjiv President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2021-03-26 | Catinazzo Thomas Senior Vice President, Finance | Grant or award | +15,870 | 15,870 | ||
| 2021-03-26 | Catinazzo Thomas Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +31,740 | 31,740 |
Page 24 of 27 · 534 trades